24/7 Market News Snapshot 03 September, 2024 – Rockwell Medical, Inc. (DE) Common Stock (NASDAQ:RMTI)

September 3, 2024

DENVER, Colo., 03 September, 2024 (247marketnews.com) – (Nasdaq:RMTI) are discussed in this article.
Rockwell Medical, Inc. (Nasdaq:RMTI) is witnessing a significant surge in its stock performance, opening at $2.90 and currently trading at $3.36, marking an increase of approximately 17.52%. This positive movement follows the previous session’s close at $2.86, reflecting a strong bullish trend enhanced by robust trading volume of 817.77K shares, indicating heightened investor interest. Analysts are observing potential resistance at the $3.50 mark, while support is anticipated around $3.00. These technical levels are crucial for traders to monitor, as they will likely influence future price actions.

In conjunction with its stock performance, Rockwell Medical has announced a strategic distribution agreement with Nipro Medical Corporation, a subsidiary of Japan’s Nipro Corporation. This partnership aims to extend Rockwell Medical’s innovative hemodialysis products to a broader global market. Under this agreement, Nipro will be responsible for distributing a range of hemodialysis concentrates, which includes both liquid and dry formulations, along with a dry acid concentrates mixer. This collaboration grants Nipro global distribution rights, excluding the United States, and is set to last for two years with a commitment of a minimum purchase of $5.0 million in the first year, along with potential yearly increases.

Mark Strobeck, Ph.D., President and CEO of Rockwell Medical, expressed enthusiasm for the partnership, emphasizing the importance of enhancing patient accessibility to quality hemodialysis products. Manny Zapata, Nipro Medical’s Renal Division Manager for Latin America, echoed this viewpoint by highlighting the ongoing commitment to improving patient care through expanded access to essential dialysis solutions. Rockwell Medical continues to pursue its goal of becoming a leading global supplier of hemodialysis concentrates, all while maintaining a strong focus on innovation and quality in healthcare services.

Related news for (RMTI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.